• Streamlining Spiramycin Derivatives: Genetic Refinement of B

  2026-06-13

  The referenced study demonstrates the targeted removal of a 3-O-acyltransferase gene in Streptomyces spiramyceticus WSJ-1, resulting in the exclusive production of 400-isovalerylspiramycin I. This innovation simplifies component profiles in bitespiramycin biosynthesis, offering greater consistency for antimicrobial research and potential clinical development.

• Biotin-tyramide: Technical Guide for TSA Signal Amplificatio

  2026-06-12

  Biotin-tyramide is a specialized biotinylation reagent for enzyme-mediated signal amplification in immunohistochemistry (IHC), in situ hybridization (ISH), and related imaging techniques. It addresses the need for sensitive and spatially precise detection of low-abundance targets in fixed cells and tissues using tyramide signal amplification. This reagent is not suitable for diagnostic or in vivo applications and should be handled according to strict solubility and storage guidelines.

• Filipin III: Precision Cholesterol Probing in Tumor Immunome

  2026-06-12

  Explore how Filipin III, a polyene macrolide antibiotic, is redefining cholesterol detection in membrane biology and tumor immunometabolism. This cornerstone article uniquely connects advanced cholesterol visualization with cutting-edge immunometabolic research.

• ELF4 Drives Colorectal Cancer Metastasis via FGFR4 and SRC A

  2026-06-11

  This study identifies E74-like factor 4 (ELF4) as a central driver of colorectal cancer metastasis, functioning through transcriptional activation of FGFR4 and SRC. The findings clarify a clinically relevant molecular axis and provide a foundation for targeted therapeutic strategies in metastatic colorectal cancer.

• L-Ornithine (B8919): Biochemical Rationale, Evidence, and Re

  2026-06-11

  L-Ornithine, or (S)-2,5-diaminopentanoic acid, is a non-proteinogenic amino acid essential for urea cycle and ammonia detoxification research. Recent studies clarify its mechanistic impact on hepatic and neural metabolic pathways, with APExBIO’s B8919 providing high-purity reagent support.

• Ibrexafungerp (MK 3118): Advanced Antifungal Workflows & Ins

  2026-06-10

  Ibrexafungerp (MK 3118) empowers antifungal research with robust activity against fluconazole- and echinocandin-resistant Candida, even under acidic conditions typical of vulvovaginal infections. This article delivers practical protocols, troubleshooting strategies, and translational insight for maximizing experimental success with this oral triterpenoid agent.

• Applied Workflows with EZ Cap™ Human PTEN mRNA (ψUTP): Proto

  2026-06-10

  EZ Cap™ Human PTEN mRNA (ψUTP) unlocks robust PTEN restoration and pathway inhibition in advanced cancer models, thanks to its engineered Cap 1 structure and pseudouridine modification. This guide translates cutting-edge reference study findings and expert workflow insights into actionable, high-fidelity protocols for translational and functional rescue research.

• Hexose Diphosphate in Energy Homeostasis and Inflammation Mo

  2026-06-09

  Hexose diphosphate empowers precise dissection of metabolic flux and inflammatory pathways in cardiovascular and aging research. This guide details robust workflows, troubleshooting, and protocol enhancements for leveraging this water-soluble, metabolically active compound in both standard and advanced cellular assays.

• Omeprazole (A2845): Technical Guide for Gastric Acid Models

  2026-06-09

  Omeprazole (SKU A2845) is a high-purity H+,K+-ATPase inhibitor optimized for in vitro and preclinical research on gastric acid secretion mechanisms and antiulcer activity. It should not be used for diagnostic or clinical applications. Precise handling and protocol adherence are essential to ensure reproducible results in gastric acid-related disorder studies.

• HyperPFU™ high-fidelity DNA polymerase: Technical Use Guidan

  2026-06-08

  HyperPFU™ high-fidelity DNA polymerase addresses the challenge of amplifying long, GC-rich, or otherwise difficult DNA templates that standard enzymes struggle with due to low fidelity or processivity. This enzyme is optimal for workflows demanding high accuracy and blunt-ended PCR products, but is not suitable for protocols requiring 3'-A overhangs or sticky-end ligation.

• BCL-XL and MCL-1 Inhibition Sensitizes Glioblastoma to Apopt

  2026-06-08

  Koessinger et al. demonstrate that glioblastoma displays heightened expression of anti-apoptotic BCL-XL and MCL-1, rendering these tumors highly sensitive to BH3-mimetic inhibitors. Their work reveals a critical vulnerability in glioblastoma stem-like cells and provides a rationale for targeting BCL-2 family proteins to overcome therapeutic resistance.

• Tomivosertib Reversibly Suppresses Human DRG Neuron Hyperact

  2026-06-07

  This study demonstrates that Tomivosertib, a selective MNK1/2 inhibitor, rapidly and reversibly suppresses spontaneous activity in human dorsal root ganglion neurons derived from patients with radiculopathy. The findings provide direct evidence linking MNK-eIF4E signaling to neuronal hyperexcitability in neuropathic pain, highlighting a new translational target for pain research.

• Scenario-Driven Lab Solutions with MCL-1 Inhibitor A-1210477

  2026-06-06

  Discover how 'MCL-1 inhibitor A-1210477' (SKU B6011) offers reproducible, data-backed answers to common challenges in apoptosis assays and cancer cell survival research. This scenario-driven guide distills evidence and expert workflow advice for reliable protocol development and product selection.

• Myriocin Restores Metabolic Balance via AMPK-PGC1α in dAGE M

  2026-06-05

  This study demonstrates that Myriocin, a serine palmitoyltransferase inhibitor, reverses diet-induced metabolic syndrome in mice by activating AMPK-PGC1α signaling, promoting mitochondrial biogenesis and adipose tissue browning. The findings reveal sphingolipid inhibition as a promising approach for obesity and metabolic disorder research.

• Meropenem Trihydrate in Resistance & Infection Research Work

  2026-06-05

  Meropenem trihydrate stands at the forefront of antibiotic resistance research, enabling rapid phenotyping and translational modeling of gram-negative and gram-positive infections. This guide delivers expert workflows, troubleshooting, and data-driven insights that maximize reproducibility and reveal new diagnostic possibilities.

16109 records 1/1074 page Next 12345 下5页 Last page